Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 1
2009 1
2010 1
2011 1
2012 1
2014 1
2015 5
2016 4
2017 3
2018 2
2019 4
2020 3
2021 3
2022 8
2023 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

35 results

Results by year

Filters applied: . Clear all
Page 1
Extracellular vimentin mimics VEGF and is a target for anti-angiogenic immunotherapy.
van Beijnum JR, Huijbers EJM, van Loon K, Blanas A, Akbari P, Roos A, Wong TJ, Denisov SS, Hackeng TM, Jimenez CR, Nowak-Sliwinska P, Griffioen AW. van Beijnum JR, et al. Among authors: huijbers ejm. Nat Commun. 2022 May 23;13(1):2842. doi: 10.1038/s41467-022-30063-7. Nat Commun. 2022. PMID: 35606362 Free PMC article.
Proinflammatory activity of VEGF-targeted treatment through reversal of tumor endothelial cell anergy.
Nowak-Sliwinska P, van Beijnum JR, Griffioen CJ, Huinen ZR, Sopesens NG, Schulz R, Jenkins SV, Dings RPM, Groenendijk FH, Huijbers EJM, Thijssen VLJL, Jonasch E, Vyth-Dreese FA, Jordanova ES, Bex A, Bernards R, de Gruijl TD, Griffioen AW. Nowak-Sliwinska P, et al. Among authors: huijbers ejm. Angiogenesis. 2023 May;26(2):279-293. doi: 10.1007/s10456-022-09863-4. Epub 2022 Dec 2. Angiogenesis. 2023. PMID: 36459240 Free PMC article.
Extracellular vimentin as a versatile immune suppressive protein in cancer.
van Loon K, van Breest Smallenburg ME, Huijbers EJM, Griffioen AW, van Beijnum JR. van Loon K, et al. Among authors: huijbers ejm. Biochim Biophys Acta Rev Cancer. 2023 Nov;1878(6):188985. doi: 10.1016/j.bbcan.2023.188985. Epub 2023 Sep 17. Biochim Biophys Acta Rev Cancer. 2023. PMID: 37717859 Free article. Review.
Vaccination approach to anti-angiogenic treatment of cancer.
Wentink MQ, Huijbers EJ, de Gruijl TD, Verheul HM, Olsson AK, Griffioen AW. Wentink MQ, et al. Among authors: huijbers ej. Biochim Biophys Acta. 2015 Apr;1855(2):155-71. doi: 10.1016/j.bbcan.2015.01.005. Epub 2015 Jan 30. Biochim Biophys Acta. 2015. PMID: 25641676 Review.
Directing CAR T cells towards the tumor vasculature for the treatment of solid tumors.
Akbari P, Katsarou A, Daghighian R, van Mil LWHG, Huijbers EJM, Griffioen AW, van Beijnum JR. Akbari P, et al. Among authors: huijbers ejm. Biochim Biophys Acta Rev Cancer. 2022 May;1877(3):188701. doi: 10.1016/j.bbcan.2022.188701. Epub 2022 Feb 22. Biochim Biophys Acta Rev Cancer. 2022. PMID: 35202772 Free article. Review.
Role of the tumor stroma in resistance to anti-angiogenic therapy.
Huijbers EJ, van Beijnum JR, Thijssen VL, Sabrkhany S, Nowak-Sliwinska P, Griffioen AW. Huijbers EJ, et al. Drug Resist Updat. 2016 Mar;25:26-37. doi: 10.1016/j.drup.2016.02.002. Epub 2016 Feb 24. Drug Resist Updat. 2016. PMID: 27155374 Review.
35 results